RenovoRx, Inc.
RNXT
$0.85
-$0.02-2.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.53% | -36.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.53% | -36.97% | |||
| Cost of Revenue | -47.17% | -65.13% | |||
| Gross Profit | -1.41% | -21.11% | |||
| SG&A Expenses | 29.11% | 13.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.94% | 11.80% | |||
| Operating Income | 5.56% | -19.49% | |||
| Income Before Tax | -1.00% | -0.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.00% | -0.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.00% | -0.59% | |||
| EBIT | 5.56% | -19.49% | |||
| EBITDA | 5.58% | -19.52% | |||
| EPS Basic | -0.88% | -0.51% | |||
| Normalized Basic EPS | 16.30% | -0.40% | |||
| EPS Diluted | -0.88% | -0.51% | |||
| Normalized Diluted EPS | 16.30% | -0.40% | |||
| Average Basic Shares Outstanding | 0.03% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||